标题：FibroScan在慢性乙肝肝纤维化检测中相关影响因素的研究进展

      作者：李钦 1 综述 梁跃东 2 审校    1.贵州医科大学，贵州 贵阳 550004；2.贵阳市公共卫生救治中心，贵州 贵阳 550004

      卷次： 2019年30卷21期

      【摘要】 FibroScan (FS)检测广泛运用于慢性乙肝肝纤维化程度评估，它属于无创检查，取样较肝穿刺病理活检大，与肝脏组织学有较高一致性，易于重复操作、患者接受程度高，目前在临床上广泛应用，但其检测结果受多种因素影响，故FS检测肝纤维化程度还需结合相关因素进行评判。
      【关键词】 Fibroscan；慢性乙肝；肝纤维化；影响因素；研究进展
      【中图分类号】 R512.6+2 【文献标识码】 A 【文章编号】 1003—6350（2019）21—2821—04

Research progress of FibroScan in the detection of fibrosis in chronic hepatitis B affected by relevant factors.
LIQin 1, LIANG Yue-dong 2. 1. Guizhou Medical University, Guiyang 550004, Guizhou, CHINA; 2. Public Health TreatmentCenter of Guiyang, Guiyang 550004, Guizhou, CHINA【Abstract】 FibroScan (FS) is a non-invasive test widely used to evaluate the degree of liver fibrosis in chronichepatitis B. Its sampling requirements are larger than that of the pathological biopsy of liver puncture and have high con-sistency with liver histology. It has the advantage of easy repetitive operation and high patient acceptance. At present, al-though this method is widely used in clinical practice, its detection results are affected by many factors, so it is necessaryto evaluate the effect of FS detection on the degree of liver fibrosis by combining relevant factors.
      【Key words】 FibroScan; Chronic hepatitis B; Liver fibrosis; Influencing factors; Research progress·综述·doi:10.3969/j.issn.1003-6350.2019.21.030